Evidence map›Paper›PMID 12734753›Full record

ArticleJournal of cancer research and clinical oncology2003

Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.

Lian-Hai Zhang, Lun-Xiu Qin, Zeng-Chen Ma, Sheng-Long Ye, Yin-Kun Liu, Qing-Hai Ye, Xin Wu, Wei Huang, Zhao-You Tang

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Biomarker in Hepatocellular Carcinoma.Indian journal of surgical oncology · 2024
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Molecular genetics of hepatocellular neoplasia.American journal of translational research · 2010
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of estrogen in the initiation of breast cancer.The Journal of steroid biochemistry and molecular biology · 2006
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. A decade's studies on metastasis of hepatocellular carcinoma.Journal of cancer research and clinical oncology · 2004
    Review
  18. Article
  19. Review
  20. The prognostic molecular markers in hepatocellular carcinoma.World journal of gastroenterology · 2002
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Lian-Hai ZhangLiver Cancer Institute, Fudan University, 136 Yi Xue Yuan Road, 200032, Shanghai, China.
Lun-Xiu Qin
Zeng-Chen Ma
Sheng-Long Ye
Yin-Kun Liu
Qing-Hai Ye
Xin Wu
Wei Huang
Zhao-You Tang
Zhongshan Hospital · CNFudan University · CNSun Yat-sen University · CNChinese National Human Genome Center at Shanghai · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To understand the molecular mechanisms of metastasis in hepatocellular carcinoma (HCC), it is necessary to identify the accumulating genetic alterations during its progression as well as those responsible for the acquisition of metastatic potential in cancer cells. In our previous study, using comparative genomic hybridization (CGH), we found that loss on chromosome 8p is more frequent in metastatic lesions than in matched primary tumors of HCC. Thus, 8p deletion might contribute to HCC metastasis. To narrow the location of metastasis-related alteration regions, we analyzed 22 primary and matched metastatic lesions of HCC by genome-wide microsatellite analysis. Common regions with high levels of allelic imbalance (AI) were identified on 17p, 8p11-cen, 8p21-23, 4q32-qter, 4q13-23, 16q, and 1p33. Regions with increased AI in metastatic lesions were 8p23.3, 8p11.2, 17p11.2-13.3, 4q21-22, 4q32-qter, 8q24.1, 9p11, 9q31, 11q23.1, 13q14.1-31, 13q32-qter, 16p13.3, 16q13, 16q22, and 19p13.1, and these were considered to be related to the metastasis phenotype. Among them, loss on 8p was again proved to be related to progression and metastasis of HCC, and 8p23.3 and 8p11.2 were two likely regions harboring metastasis-related genes. It was also shown for the first time in HCC that AI of 19p13.1 might also be related to metastatic potential. These results provide some candidate regions for further study to identify putative genes suppressing metastasis of HCC.

Indexed as

Allelic ImbalanceMicrosatellite RepeatsAdultAgedCarcinoma, HepatocellularChromosomes, Human, Pair 17Chromosomes, Human, Pair 19Chromosomes, Human, Pair 8Disease ProgressionFemaleHumansLiver NeoplasmsMaleMiddle AgedPolymerase Chain Reaction

Identifiers

PMID12734753
PMCPMC12161956
OpenAlexW1542110088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.